Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
Nano Dimension Reports Financial Results for the Second Quarter 2026
Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board
Nano Dimension Appoints Moshe Rozenbaum Interim CEO, Phillip Borenstein As Board Chairman, Effective Immediately
Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company’s Board of Directors
Nano Dimension And Murchinson Announce Settlement; July EGM Cancelled, Four Directors Resign, Three Murchinson Nominees Join Board
Nano Dimension Continues Execution of Cost Savings Initiatives
Nano Dimension Inks Agreement To Terminate Lease For Its Current Corporate HQs, Effective Dec. 31 As Part Of Cost Savings Initiative
Nano Dimension (NNDM) Issues Update on Infinite Epigenetics Combination
Nano Dimension Board Sets the Record Straight on Murchinson's Self-Interested and Destructive Campaign
Here’s Why Nano Dimension (NNDM) is Among the 8 High Growth Penny Stocks to Buy
Nano Dimension: Controversial Move Offers Promise Amidst Uncertainty (Rating Downgrade)
Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination
Murchinson Criticizes the Nano Dimension Board of Directors’ Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics
Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company
Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript
Nano Dimension Strikes Term Sheet For Proposed Merger With Infinite Epigenetics
Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?
Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin
Nano Dimension Publishes CEO Letter Addressing Buybacks And Personal Shareholdings
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.